Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
Abstract
Fluoxetine injected i.p. into rats at a dose of 10 mg/kg rapidly increased serotonin concentration in microdialysis fluid from the striatum by at least 4-fold, an increase that was maintained throughout the 3 hr observation period. Dopamine concentration in the microdialysis fluid did not change. The concentration of the two dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, was not changed in the microdialysis fluid, whereas the concentration of the serotonin metabolite, 5-hydroxyindoleacetic acid, was significantly decreased after fluoxetine injection. The increased extracellular concentration of serotonin no doubt resulted from inhibition of the serotonin uptake carrier by fluoxetine, and the lack of change in dopamine is evidence for the specificity of action of this uptake inhibitor.
References (24)
- C.A. Marsden et al.
Brain Res.
(1979) - X-M. Guan et al.
Brain Res. Bull.
(1988) - S.S. Auerbach et al.
Brain Res.
(1989) - L.A. Phebus et al.
Life Sci.
(1986) - R.W. Fuller et al.
Life Sci.
(1974) - D.H. Schwartz et al.
Brain Res. Bull.
(1990) - E. Carboni et al.
Neurosci.
(1989) - P.C. Waldmeier et al.
Eur. J. Pharmacol.
(1979) - M.G. De Simoni et al.
Brain Res.
(1987) - R.W. Fuller et al.
Drug Develop. Res.
(1989)
Ann. N.Y. Acad. Sci.
J. Pharmacol. Exp. Ther.
Cited by (216)
Sex and social status modify the effects of fluoxetine on socioemotional behaviors in Syrian hamsters and rhesus macaques
2022, Pharmacology Biochemistry and BehaviorSocial subordination increases risk for psychiatric disorders, while dominance increases resilience to these disorders. Fluoxetine, a selective serotonin (5HT) reuptake inhibitor whose actions are mediated in part by the 5HT1A receptor (5HT1AR), has sex- and social status-specific effects on socioemotional behavior and aggressive behavior. However, the impact of social status on these sex-specific effects remains unclear. The current study evaluated the impact of acute fluoxetine treatment and social status on dominance-related behaviors in female and male hamsters, and the impact of chronic fluoxetine treatment on socioemotional behavior and 5HT1AR binding potential (5HT1ARBP) in female rhesus macaques. We hypothesized that sex differences in the effects of fluoxetine on aggression in hamsters would be diminished in dominant and enhanced in subordinate males and that aggression in female hamsters would be enhanced in dominants and diminished in subordinates. In female rhesus macaques, we hypothesized that chronic fluoxetine would alter socioemotional behaviors and site-specific 5HT1ARBP in a status-dependent manner. Male (n = 46) and female (n = 56) hamsters were paired with conspecifics for three days to establish social rank. Hamsters received a single dose of 20 mg/kg fluoxetine or vehicle two-hours prior to a test with a non-aggressive intruder. Female rhesus monkeys (n = 14) housed were administered fluoxetine (2.8 mg/kg/day) or vehicle injections chronically for 14-days, separated by a three-week washout period. On Day 15, positron emission tomography neuroimaging for 5HT1ARBP was conducted. Fluoxetine treatment decreased aggression in subordinate female monkeys and subordinate female hamsters but not in dominant females of either species. Fluoxetine decreased aggression in dominant but not in subordinate male hamsters. Fluoxetine also reduced and increased prefrontal 5HT1ARBP in dominant and subordinate females, respectively. Taken together, these results provide cross-species evidence that social status and sex impact how increased 5HT modulates agonistic behavior.
Transcriptional analyses reveal different mechanism of toxicity for a chronic exposure to fluoxetine and venlafaxine on the brain of the marine fish Dicentrarchrus labrax
2021, Comparative Biochemistry and Physiology Part - C: Toxicology and PharmacologySelective serotonin reuptake inhibitor (SSRI) and serotonin norepinephrine reuptake inhibitor (SNRI) are prescribed for clinical depression and detected in aquatic ecosystems. The main aim of this study was to explore and evaluate transcriptional responses of neurotransmitter genes in the brain of a marine fish species, European seabass, and to analyze global brain transcriptomic changes by a RNA-seq technology (MACE, massive analysis of cDNA ends). The juveniles were exposed to two psychopharmaceuticals: (i) fluoxetine (FLX) at the concentration of 0.5 μg/L and 50 μg/L; (ii) venlafaxine (VENX) at the concentration of 0.01 μg/L and 1 μg/L. The exposures were performed for 21 days, followed by a 7-day recovery period to assess the reversibility of effects. Both psychopharmaceuticals affected differentially the neurotransmitter mRNA expression analyzed by RT-qPCR (serotonin receptors: 5-ht3a, 5-ht3b; dopamine receptors: d2, d3; neurotransmitter transporter: sert, vmat; degrading enzyme: mao). Transcriptomic analyses after 21 days of exposure revealed 689 and 632 significant different transcripts by FLX at 0.5 and 50 μg/L, respectively, and 432 and 1250 by VENX at 0.01 and 1 μg/L, respectively, and confirmed different mechanism of toxicity between both compounds. At environmental concentrations, more general pathways including energy metabolism were affected, while at the higher concentration effects on neurotransmitter pathways were observed (FLX: exocytosis and vesicle formation; VENX: small molecule catabolism regulating dopamine and tyrosine level). These results provided new insights into the chronic effects of psychopharmaceutical compounds on marine fish and suggest the need of a separate ecotoxicological risk analysis.
Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence
2021, Progress in Brain ResearchThe interaction between serotonin (5-HT) and dopamine (DA) in the central nervous system (CNS) plays an important role in the adaptive properties of living animals to their environment. These are two modulatory, divergent systems shaping and regulating in a widespread manner the activity of neurobiological networks and their interaction. The concept of one interaction linking these two systems is rather elusive when looking at the mechanisms triggered by these two systems across the CNS. The great variety of their interacting mechanisms is in part due to the diversity of their neuronal origin, the density of their fibers in a given CNS region, the distinct expression of their numerous receptors in the CNS, the heterogeneity of their intracellular signaling pathway that depend on the cellular type expressing their receptors, and the state of activity of neurobiological networks, conditioning the outcome of their mutual influences. Thus, originally conceptualized as inhibition of 5-HT on DA neuron activity and DA neurotransmission, this interaction is nowadays considered as a multifaceted, mutual influence of these two systems in the regulation of CNS functions. These new ways of understanding this interaction are of utmost importance to envision the consequences of their dysfunctions underlined in several CNS diseases. It is also essential to conceive the mechanism of action of psychotropic drugs directly acting on their function including antipsychotic, antidepressant, antiparkinsonian, and drug of abuse together with the development of therapeutic strategies of Alzheimer's diseases, epilepsy, obsessional compulsive disorders. The 5-HT/DA interaction has a long history from the serendipitous discovery of antidepressants and antipsychotics to the future, rationalized treatments of CNS disorders.
Serotonin regulation of striatal function
2020, Handbook of Behavioral NeuroscienceSerotonin plays an important yet underappreciated role in the physiology and function of the striatum, impacting numerous behaviors including reward seeking, decision-making, and motor planning. This review discusses how the anatomical pattern of innervation of striatum by serotonergic neurons from midbrain raphe and the complex distribution of serotonin receptors within striatum impact how serotonin modulates the striatal function. We highlight data from studies employing in vivo microdialysis to discuss the neurochemistry of striatal serotonin receptors with respect to their role on serotonin and dopamine release. Finally, we discuss behaviors impacted by serotonin in the striatum and attempt to provide a framework to understand the complicated role of serotonin in modulating the striatum neurochemically, behaviorally, and functionally.
Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation
2019, Progress in Neuro-Psychopharmacology and Biological PsychiatryTreatment-resistant depression (TRD) is a major public health issue, as it is common for patients with depression to fail to respond to adequate trials of antidepressants. However, a well-established animal model of TRD is still warranted. The present study focused on selective serotonin reuptake inhibitor (SSRI) resistance, and aimed to investigate whether higher levels of traumatic stress caused by greater numbers of foot-shocks may lead to severe depression and to examine the feasibility of this as an animal model of SSRI-resistant depression. To reveal the correlation between traumatic stress and severe depression, rats received 3, 6 and 10 tone (conditioned stimulus, CS)–shock (unconditioned stimulus, US) pairings to mimic mild, moderate, and severe traumatic events, and subsequent depressive-like behaviors and protein immunocontents were analyzed. The antidepressant efficacy was assessed for ketamine and SSRI (i.e., fluoxetine) treatment. We found that only the severe stress group presented depressive-like behaviors. Phosphorylation of extracellular signal-regulated kinases (ERKs) was decreased in the amygdala and prefrontal cortex (PFC). The immunocontents of GluA1 and PSD 95 were increased in the amygdala and decreased in the PFC. Moreover, the glutamate-related abnormalities in the amygdala and PFC were normalized by single-dose (10 mg/kg, i.p.) ketamine treatment. In contrast, the depressive-like behaviors were not reversed by 28 days of fluoxetine treatment (10 mg/kg, i.p.) in the severe stress group. Our data demonstrated that high levels of traumatic stress could lead to SSRI-resistant depressive symptoms through impacts on the glutamatergic system, and that this rat model has the potential to be a feasible animal model of SSRI-resistant depression.
RuO<inf>2</inf> nanowires on electrospun CeO<inf>2</inf>-Au nanofibers/functionalized carbon nanotubes/graphite oxide nanocomposite modified screen-printed carbon electrode for simultaneous determination of serotonin, dopamine and ascorbic acid
2019, Journal of Alloys and CompoundsIn this work, for the first time, a novel hybrid architecture of CeO2-Au nanofibers (CeO2-AuNFs) and single-crystalline RuO2 nanowires (RuO2NWs) have been synthesized by a combination of electrospinning and thermal annealing process. The CeO2-Au hybrid nanofibers were fabricated by the electrospinning technique and then annealed in air. The amorphous Ru(OH)3 precursors at relatively low temperature were efficiently converted into highly single-crystalline RuO2NWs on electrospun CeO2-AuNFs. Novel RuO2NWs–CeO2-AuNFs hybrid architecture in combination with graphite oxide (GO) and functionalized multiwalled carbon nanotubes (f-MWCNTs) further employed to modify screen printed carbon electrode (SPCE(in order to develop a sensitive electrochemical method with suitable properties for the simultaneous determination of serotonin (5-HT), dopamine (DA) and ascorbic acid (AA). Under the optimum operating conditions, linear calibration curves were obtained in the range of 0.01–150, 0.01–120 and 0.5–100 μM with a detection limit of 2.4, 2.8 and 160 nM for 5-HT, DA and AA, respectively. The proposed electrochemical sensor decreased the overpotentials as well as resolved the overlapping of the oxidation peak potentials. This sensor was successfully applied for the determination of 5-HT, DA and AA in biological fluids and pharmaceutical samples.